Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-038070 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
290,173
Total Value
$374,293.59
P&L
+inf% (+$4,492,014.20)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 2, 2026 | Grant/Award | 37,522 | $0.00 | $0.00 | 1,659,773 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 3, 2026 | Sale | 30,186 | $12.26 | $369,998.86 | 1,629,587 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 3, 2026 | Sale | 333 | $12.90 | $4,294.73 | 1,629,254 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 222,132 | $0.00 | $0.00 | 222,132 | Direct | โ | View Details |